Announcements Trials
Browse Landscape

Phase

Phase 3 29Phase 2 16Phase 1/2 4Phase 4 3Phase 1 3Phase NA 2Phase 2/3 2Phase EARLY_PHASE1 1

Status

Completed 2Not yet recruiting 1

Sponsor Class

OTHER 2INDUSTRY 1

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 10Gynecologic 3Genitourinary 3Thoracic 1Other solid neoplasm 1Other hematologic neoplasm 1

Conditions

Urinary Bladder Neoplasms 2Urothelial Carcinoma Ureter 1Non-Muscle Invasive Bladder Neoplasms 1

Interventions

pembrolizumab 93Nivolumab 61Docetaxel 55Cyclophosphamide 49enzalutamide 44Magnetic Resonance Spectroscopy 33Ipilimumab 33Gemcitabine 32Abiraterone Acetate 30Prednisone 29fludarabine 28Everolimus 27Paclitaxel 25Cisplatin 24Radiotherapy 23Carboplatin 23Sunitinib 22cabozantinib 21atezolizumab 20Radiosurgery 20Specimen Handling 19Sorafenib 18Bevacizumab 18pazopanib 17bicalutamide 17abiraterone 17Biopsy 15temsirolimus 14darolutamide 14apalutamide 14

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 1 × Mitomycin × Genitourinary × Clear all
NCT05979909 2023-08-07

Intravesical Mitomycin C After Diagnostic Ureteroscopy for Upper Tract Urothelial Carcinoma

McMaster University

Phase 1 Not yet recruiting
40 enrolled
Genitourinary

Urothelial Carcinoma Ureter

NCT02316171 2022-07-27

CANON

Viralytics

Phase 1 Completed
16 enrolled 8 charts
Genitourinary

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms

NCT02311101 2015-12-03

Phase I Mitomycin Combined With Bacillus Calmette-Guérin (BCG) for Bladder Cancer

The University of Texas Health Science Center at San Antonio

Phase 1 Completed
18 enrolled
Genitourinary

Urinary Bladder Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡